EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Effect of electronic drug-drug interaction alerts on patient and clinician outcomes: a systematic review

Anne M Holbrook, Jessyca Matos Silva iD, Junaid Ahmed Yaser Faruque, Jiawen Deng, Tyler Schneider, Aliya Jaffer

Journal of the American Medical Informatics Association · 01.10.2025 · 32 (10) · 1617-1628

DOI: 10.1093/jamia/ocaf139 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of the American Medical Informatics Association, online erschienen am 25.08.2025. Verfasst von Anne M Holbrook und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacology and Toxicology, Department of Medicine, McMaster University, Hamilton, ON, L8S 4L8, Canada. Hauptthemen laut MEDLINE: Decision Support Systems, Clinical, Medical Order Entry Systems. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ontario Ministry of Health and Long Term Care, peer-reviewed Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Drug interaction checking software is ubiquitous in clinical decision support systems (CDSS-DI) but patient relevance and accuracy are variable and the impact on patient outcomes is unproven. We compared the effectiveness of CDSS-DI with similar care without CDSS-DI. Materials and Methods We searched multiple bibliographic databases from 1990 to end-2024 for randomized trials (RCTs) or prospective cohort studies evaluating CDSS-DI at prescription, dispensing, or administration compared to a control group, and assessing clinical, process and burden outcomes. We used Cochrane Risk of Bias v2.0 and ROBINS-I to assess risk of bias and random effects modeling using meta 6.0 package in R for meta-analysis.

Results

Eight studies were included—7 RCTs (2 parallel and 5 cluster) and 1 prospective cohort study (total N = 43 413 patients). Mortality rates were similar between intervention (0.14%) and control (0.07%) groups (OR: 1.94 [95% CI: 0.88-4.29], P = .078). One study reported a minor, possibly irrelevant, 3-hour decrease in length of stay (P = .0021) in the intervention group. CDSS-DI alerts modestly influenced prescribing behavior (OR: 2.08 [95% CI: 1.01-4.27], P = .05), but did not significantly reduce the incidence of targeted adverse drug interactions (OR: 0.86 [95% CI: 0.56-1.34], P = .37).

Discussion

Surprisingly little high-quality research addresses the effect of CDSS-DI on patient or clinician outcomes. Current evidence continues to suggest no major benefit for patient-important outcomes. Given the potential for harms and important time burdens, CDSS-DI alerting needs improvement.

Conclusion

CDSS-DI alerts show no significant improvement in patient-important outcomes. Optimizing alert accuracy, clinical relevance, and patient-specific integration is essential to enhance their value in practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Decision Support Systems, ClinicalMedical Order Entry SystemsHumansDrug Interactions

Stichwörter der Autor:innen

clinical decision support systemsdrug-drug interactionsmedication safetysystematic review

Autor:innen und Institutionen

  • Division of Clinical Pharmacology and Toxicology, Department of Medicine, McMaster University, Hamilton, ON, L8S 4L8, Canada.
  • Clinical Pharmacology Research, The Research Institute of St Joe's Hamilton, Hamilton, ON, L8N 4A6, Canada.
  • Department of Health Evidence and Impact, McMaster University, Hamilton, ON, L8S 4L8, Canada.
  • AstraZeneca Canada, Mississauga, ON, L4Y 1M4, Canada.
  • Temerty Faculty of Medicine, University of Toronto, Toronto, ON, M5S 1A8, Canada.
  • eHealth Masters Program, McMaster University, Hamilton, ON, L8S 4L, Canada.

ORCID-Profile: Jessyca Matos Silva

Förderung

  • Ontario Ministry of Health and Long Term Care
  • peer-reviewed Innovation

Zitieren

APA

Holbrook, A. M., Silva, J. M., Faruque, J. A. Y., Deng, J., Schneider, T., & Jaffer, A. (2025). Effect of electronic drug-drug interaction alerts on patient and clinician outcomes: a systematic review. Journal of the American Medical Informatics Association, 32(10), 1617-1628. https://doi.org/10.1093/jamia/ocaf139

Vancouver

Holbrook AM, Silva JM, Faruque JAY, Deng J, Schneider T, Jaffer A. Effect of electronic drug-drug interaction alerts on patient and clinician outcomes: a systematic review. Journal of the American Medical Informatics Association. 2025;32(10):1617-1628. doi:10.1093/jamia/ocaf139

BibTeX
@article{Holbrook2025,
  author = {Holbrook, Anne M and Silva, Jessyca Matos and Faruque, Junaid Ahmed Yaser and Deng, Jiawen and Schneider, Tyler and Jaffer, Aliya},
  title = {Effect of electronic drug-drug interaction alerts on patient and clinician outcomes: a systematic review},
  journal = {Journal of the American Medical Informatics Association},
  year = {2025},
  volume = {32},
  number = {10},
  pages = {1617--1628},
  doi = {10.1093/jamia/ocaf139}
}
Kostenlos starten →